Moreover, the isoform BCAT1 has been proposed as a prognostic marker of glioblastoma [15], ovarian cancer [16], breast cancer [17], hepatocellular carcinoma [18], and chronic myelogenous leukemia (CML) [19]. This evidence concerns the gene BCAT1 and chronic myelogenous leukemia, BCR-ABL1 positive.